92P - Vall d’Hebron Institute of Oncology (VHIO) immuno-oncology prognostic index (VIO): A new tool for improved patient (pt) selection in phase I (Ph1) trials with immune checkpoint inhibitors (ICI)
| Autor: | Hierro, C., Matos, I., Martin-Liberal, J., Ochoa De Olza Amat, M., Felip, E., Costa Rivas, M., Vieito Villar, M., Brana, I., Azaro, A., Perez-Gago, M.C., Gros, A., Carles, J., Oaknin, A., Macarulla, T., Saura, C., pardo, N., Muñoz-Couselo, E., Tabernero, J., Dienstmann, R., Garralda, E. |
|---|---|
| Zdroj: | In Annals of Oncology October 2018 29 Supplement 8 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|